Opna Bio

Opna Bio is a clinical-stage biopharmaceutical company dedicated to developing innovative oncology therapeutics. The company's focus lies in disrupting the actions of novel cancer targets, particularly the fragile-X multifunctional RNA-binding protein (FMRP). Opna Bio's research has identified FMRP as a key player in tumor immune escape, and they are developing small molecule inhibitors to unlock tumors to immune attack. Opna Bio also targets other key cancer regulators, including EP300/CBP, BET, and TEAD, with a pipeline of promising compounds in various stages of clinical development.

Opna Bio's team boasts a proven track record of scientific expertise and commercial value creation, having advanced multiple FDA-approved drugs to market. With headquarters in Lausanne, Switzerland, and an additional site in South San Francisco, CA, Opna Bio is committed to improving the lives of cancer patients worldwide. They are actively involved in clinical trials and collaborations with leading physicians, showcasing their dedication to advancing cutting-edge research and delivering effective therapies.

Opna Bio does not explicitly state any specific job flexibility details on their website or in their job postings.

Opna Bio offers competitive compensation that includes equity and comprehensive benefits. Although specific details are not provided on their website, the company prioritizes attracting talented and motivated employees and is an equal opportunity employer, committed to fostering diversity and inclusion.

Opna Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel oncology therapeutics that target multiple drivers of cancer. They are focused on improving the lives of cancer patients by developing new treatments that disrupt the actions of key cancer targets, including the fragile-X multifunctional RNA-binding protein (FMRP) and various epigenetic regulators. Opna Bio is driven by scientific curiosity and a commitment to patients, and their team of experts has a proven track record of advancing FDA-approved drugs to market.

Opna Bio emphasizes a culture of scientific rigor, driven by a deep commitment to improving the lives of cancer patients. They value collaboration, transparency, and accountability, fostering a team environment where employees are encouraged to bring diverse skills and perspectives to help build the company. Opna fosters a spirit of scientific curiosity and innovation, promoting an environment where employees can explore new ideas and contribute to groundbreaking discoveries.

Opna Bio is committed to fostering a diverse, equitable, and inclusive workplace where all employees feel valued and respected. They strive to create an environment that celebrates differences and promotes equal opportunities for all, regardless of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.